ESG

The tech giant's recent accolades for innovation, ethics, and leadership hint at a future where AI is both powerful and responsible for nonprofits.

EP Wealth adds $390M AUM by acquiring Santa Fe's LongView, a B Corp leader, blending its national growth strategy with a deep commitment to ESG.

As millions face losing healthcare, AI startup Graici has secured $7.5M to automate Medicaid renewals, betting its data wallet can solve a national crisis.

In a new digital arms race, Dashlane's AI Scam Protection analyzes websites in real-time to stop phishing before you even enter your sensitive data.

Following a new White House mandate, Voyager Technologies is building the core infrastructure for a permanent lunar base, blending commerce and national security.

With a key drug for a rare disease nearing the finish line, Spruce adds two industry veterans to navigate the high-stakes FDA approval process.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Omilia has launched a self-learning AI platform promising 'zero-day go-live' for autonomous agents, challenging the entire customer service industry.

New Medicare rules expand access to opioid alternatives, reshaping post-surgery recovery and rewarding companies at the forefront of pain management.

As AI data centers strain power grids, a tiny new component from Microchip promises to boost power density and efficiency, fueling the next wave of computing.

A new partnership aims to slash waste and streamline clinical trials, heralding a tech-driven transformation in the backbone of drug development.

Colonial Heights schools adopt AI gun detection to boost safety, but the tech faces scrutiny over its real-world effectiveness and privacy implications.

A breakthrough in cancer therapy as Avacta's faridoxorubicin proves so safe, regulators have removed historic dosing limits tied to heart toxicity.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

A new report reveals a widening gap in auto insurance rates. While some states see relief, others face crippling price hikes. Find out why and what you can do.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

Keeper's new 2026 partner program offers tiered incentives and a cloud-native platform, aiming to make enterprise-grade privileged access management profitable for MSPs.

A New Mexico health system is betting on a full-scale AI rollout to reduce doctor burnout, improve patient care, and boost its bottom line.

National imaging giant RadNet has acquired Northwest Radiology's six centers, marking its entry into Indiana and signaling a major shift for the Midwest market.

A next-gen immunotherapy enters trials, hoping its safer design can unlock the immune system and form a potent combo against advanced solid tumors.